May 28th 2025
A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD).
Encouraging Patients With Asthma to Exercise Easier Said Than Done, Survey Finds
March 6th 2021Asthma and immunology specialists responding to a survey about physical activity for patients with asthma were mostly unaware of any guidelines but seemed willing to learn more about how to incorporate them into practice.
Read More
J&J’s COVID-19 Vaccine Moves Forward After FDA Panel Vote
February 26th 2021An FDA advisory panel Friday unanimously endorsed the third US COVID-19 vaccine, a 1-shot vaccine produced by Janssen, a subsidiary of Johnson & Johnson (J&J), and an emergency use authorization by the FDA is expected to follow shortly.
Read More
Dr Krishna Sundar: Cough Hypersensitivity Is a Key Target for Patients With Chronic Cough
February 4th 2021There needs to be a better understanding of cough drivers in patients as treatments have stopped working, said Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.
Watch
Determinants of ICS Therapy Adherence in Patients With Asthma
This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.
Read More
This Week in Managed Care: January 8, 2021
January 8th 2021This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.
Watch
Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ
December 30th 2020One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.
Watch
When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.
Watch
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
December 23rd 2020The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.
Read More
Dr Anne Reihman: Latest Respiratory Research Lacks a Definition for “Adequate Response” in Biologics
December 8th 2020Updated guidelines help to address which patients are most appropriate for biologic therapy, noted Anne Reihman, MD, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.
Watch
COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery
December 7th 2020With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.
Read More
Dr Dan Ouellette: The New ERS/ATS Guidelines Provide Information on Biologic Agents
November 29th 2020Updating guidelines requires having sufficient information on the elements that are your focus, noted Dan Ouellette, MD, MS, FCCP, senior staff physician and director of the Respiratory Ward at Henry Ford Hospital.
Watch